In his speech, Rafiyev highlighted the severe impact of the ongoing war in Ukraine on regional peace and security. He ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants ...

Orchard Therapeutics, a Kyowa Kirin company, today announced the last patient has been treated in a registrational trial ...

As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in the first participating ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs Jaguar is exploring the ...

The regulator's review comes after the French medicines agency raised questions about the effectiveness of a generic drug with sodium oxybate to treat the condition, based on three studies, and warned ...

Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial Provided by GlobeNewswire May 12, 2025, 5:40:00 AM ...

He also noted that the new medicines concerned are often launched earlier in larger countries, like Germany, Italy and Spain, where maximum profits are to be gained.

The Italian Medicines Agency AIFA and the Italian Ministry of Health have granted formal approval for NEUROBIS; a multi-centre Phase II study to evaluate safety, and efficacy of an Avextra oral ...

Right now, just 56% of all new medicines approved by the European Medicines Agency (EMA) are available to patients in England and only 54% in Scotland. This compares with 88% in Germany and 77% in ...